Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Scientific Medical Journal-Biomonthly Medical Research Journal of Ahvaz Jundishapur University of Medical Sciences. 2010; 9 (3): 298-291
en Persa | IMEMR | ID: emr-144878

RESUMEN

Gestational trophoblastic disease [GTD] is one of the rare neoplastic diseases that remains curable even with a lot of metastases, but if left untreated, it can be life threatening. We had an increase in number of GTD during recent years in Ahvaz. The aim of this study was to determine the prevalence and risk factors of trophoblastic diseases among women who were admitted in Imam Khomaini Hospital, Ahvaz, Iran. In this cross-sectional study, all hospital records related to trophoblastic diseases [n=132] were reviewed from 1996 up to 2006. Demographic and histo-pathologic data were taken using a questionnaire containing 34 questions. The Chi-square, "t" and Exact -Fisher tests were used to analyze all data. P

Asunto(s)
Humanos , Femenino , Adulto , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Estudios Transversales , Encuestas y Cuestionarios , /epidemiología , Coriocarcinoma/epidemiología , Factores de Edad
2.
Scientific Medical Journal-Quarterly Medical Research Journal Ahvaz Jundishapur University of Medical Sciences [The]. 2009; 8 (2): 213-218
en Persa | IMEMR | ID: emr-143612

RESUMEN

Missed abortion, due to its severe complications, has both medical and surgical treatments. Because of surgical complications, medical treatment has recently more commonly used. As misoprostol [a prostaglandin E[1] analogue] has oral route formulation, low expense, ease of administration and quick effect, has been widely prescribed. The aim of this study was to compare the effectiveness of misoprostol when given by vaginal with that given both vaginal plus oral misoprostol in the treatment of missed abortion in the first trimester. In this clinical trial, which was performed during 2007, 98 patients with missed abortion who were referred to Ahvaz Imam Khomeini and Razi hospitals were enrolled and divided into two groups with 49 patients in each. Group I was prescribed 800 micro g of vaginal misoprostol and every 12-24 hours, an additional 800 micro g was administered. Group n was prescribed 400 micro g of oral and 400 micro g of vaginal misoprostol simultaneously with additional 400 micro g of vaginal misoprostol every 8 hours. For analysis of the data ANOVA and Chi squared tests and SPSS 13 software were used. Vaginal bleeding started significantly sooner in group I than group n 4 hour and 23 minute in contrast to 7 hour and 2 minute [P< 0.05]. Group I expelled gestational products more than group 39[76/5%] in contrast to 12[23/5%] [P< 0.05]. Patients in group I had less complications including nausea, vomiting, diarrhea, fever than the patients in group II [P<0.01]. The overall results of this study confirms the previous studies that misoprostol is an effective drug in controlling complications of first trimesters missed abortions. Furthermore vaginal route of administration is preferable method to vaginal plus oral route for treatment of missed abortion


Asunto(s)
Humanos , Femenino , Alprostadil , Misoprostol/administración & dosificación , Misoprostol , Administración Oral , Administración Intravaginal , Embarazo , Primer Trimestre del Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA